BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190905
DTEND;VALUE=DATE:20190907
DTSTAMP:20190904T074240Z
CREATED:20190904T074157Z
LAST-MODIFIED:20190904T074240Z
UID:20048-1567641600-1567814399@senzagen.com
SUMMARY:The 29th Annual BioInterface Workshop & Symposium
DESCRIPTION:
URL:https://senzagen.com/event/the-29th-annual-biointerface-workshop-symposium-2/
LOCATION:Park City\, USA\, UT\, United States
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/biointerface-2019-b-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190908
DTEND;VALUE=DATE:20190912
DTSTAMP:20190904T070917Z
CREATED:20190520T115547Z
LAST-MODIFIED:20190904T070917Z
UID:19586-1567900800-1568246399@senzagen.com
SUMMARY:EUROTOX 2019
DESCRIPTION:Will you be at Eurotox in Helsinki in September? We are looking forward to meeting you and to share the latest news about the GARD assay platform development. \nAt the conference\, we will launch GARD®skin Medical Device for biocompatibility assessment of medical devices. Our expert Dr Rose-Marie Jenvert will attend and present a poster during the session on Monday 9 Sept. Read more or book a meeting with her to learn more about this exciting new assay! \nWe will also present our latest data on solvent selection at the same poster session. Dr Olivia Larne will be available to answer your questions.\n\nMeet our team at our booth #36! \nView our posters\n \nID 482 | Viewing 1 | Board no P06-054 | Monday\, Sept 9 from 09:00\nIn vitro skin sensitization testing of Medical Devices using GARD® \nID 835 | Viewing 1 | Board number P-06-100 | Monday\, Sept 9 from 09:00\nExtended solvent selection for in vitro sensitization testing using GARD®
URL:https://senzagen.com/event/eurotox-2019/
LOCATION:Helsinki\, Finland\, Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/05/eurotox19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190919
DTSTAMP:20190917T105358Z
CREATED:20190903T122804Z
LAST-MODIFIED:20190917T105358Z
UID:20037-1568764800-1568851199@senzagen.com
SUMMARY:North American Biocompatibility Summit (NABS)
DESCRIPTION:(NABS)\, a limited-seating event that will provide industry insights and expertise sharing on the biocompatibility of medical devices\, including the latest regulatory updates\, biological evaluation strategies and best practices that lead to successful biocompatibility programs. \nSessions will be led by the medical device industry’s foremost biological safety experts.
URL:https://senzagen.com/event/north-american-biocompatibility-summit-nabs/
LOCATION:Minneapolis\, USA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/nabs-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190927
DTSTAMP:20190919T112809Z
CREATED:20190904T152040Z
LAST-MODIFIED:20190919T112809Z
UID:20064-1569283200-1569542399@senzagen.com
SUMMARY:8th Annual Meeting of the ASCCT
DESCRIPTION:Computational Toxicology: Peeking into the Clouds while Keeping our Feet on Solid Ground \nThursday\, September 26\n9:50: Session III\nThe GARD platform: Cutting-edge technology using genomics and machine learning to test for various toxicological endpoints (Schmidt\, Senzagen)
URL:https://senzagen.com/event/8th-annual-meeting-of-the-ascct/
LOCATION:Gaithersburg\, Md\, USA
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/ascct-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190926
DTSTAMP:20190918T160256Z
CREATED:20190821T125536Z
LAST-MODIFIED:20190918T160256Z
UID:19919-1569369600-1569455999@senzagen.com
SUMMARY:Free webinar: How are the in vitro GARD™assays used in real life?
DESCRIPTION:Cases and applications for testing of skin and respiratory sensitizers\nJoin Dr Andy Forreryd from SenzaGen for a webinar on how the in vitro GARD assays are used across industries to test for skin and respiratory sensitizers. Andy will focus on the benefits of the GARD assays and walk you through several relevant examples of their applications. \nKey takeways\n\nHow the GARD assays are used for assessment of UVCBs\, hair dye products\, oil-based mixtures\, base formulations and medical devices.\nHow to differentiate between skin sensitizers and respiratory sensitizers by combining GARDskin and GARDair.\nHow to obtain potency classifications (GHS CLP) using GARDpotency.\n\n  \nAvailable on two occasions\nEU Time Zone | 25 Sept\, 15:00 CET | > Register here  \nUS Time Zone | 25 Sept\, 13:00 EDT| > Register here \n  \nAbout GARD\nHigh information\, high accuracy\nThe GARD tests are developed by combining genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitizers. This holistic\, high-information approach provides robust predictions with accuracies exceeding 90%. \nWith its high accuracy\, demonstrated human relevance and broad applicability\, the GARD assays can support your unique chemical testing requirements. \nAvailable GARD assays \n\nSkin sensitization: GARDskin\, GARDskin Medical Device NEW!\nPotency classification: GARDpotency\nRespiratory sensitization: GARDair\n\n  \n  \n  \n 
URL:https://senzagen.com/event/webinar-how-are-the-in-vitro-gardassays-used-in-real-life/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
END:VCALENDAR